BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220531T090000
DTEND;TZID=America/Vancouver:20220531T103000
DTSTAMP:20220504T165613Z
CREATED:20220504T165613Z
LAST-MODIFIED:20220504T165613Z
UID:22104-1653987600-1653993000@scienceinvancouver.com
SUMMARY:What Has Gone Wrong with Publication Practices?
DESCRIPTION:As in several other scientific disciplines\, pharmaceutical sciences\, and in particularly nanomedicine is experiencing a reproducibility crisis [1]. This crisis has multiples roots\, and can be in part explained by the use of ever more complex experimental protocols and specialized systems [2]\, inaccurate or incomplete description of methods employed and lack of rigor in the design of experimental plan.  However\, another aspect that should not be ignored\, and that possibly contributes to exacerbating this problem is the drift which is currently occurring in the publication practices\, where for some groups\, sharing scientific findings ceases to be the primary reason for publishing their research findings. Using examples taken mainly from the field of drug delivery\, this presentation aims at analyzing the subtle causes that may contribute to the lack of reproducibility of the scientific literature and its impact on the society. It will also provide some possible solutions to disseminate new knowledge in a more reliable fashion. \nReferences: \n[1]. Leroux JC\, Angew. Chem. Int. Ed. 2017\, 56\, 15170-15171. \n[2]. Leroux JC\, J Control. Release 2018\, 278\, 140-141. \n\n\n\n\n\n\n\n\n\n\n\nDr. Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at the ETH Zurich\, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery\, and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS\, EURASC and the CRS\, and the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.
URL:https://scienceinvancouver.com/event/what-has-gone-wrong-with-publication-practices/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220531T090000
DTEND;TZID=America/Vancouver:20220531T103000
DTSTAMP:20220504T165613Z
CREATED:20220504T165613Z
LAST-MODIFIED:20220504T165613Z
UID:26545-1653987600-1653993000@scienceinvancouver.com
SUMMARY:What Has Gone Wrong with Publication Practices?
DESCRIPTION:As in several other scientific disciplines\, pharmaceutical sciences\, and in particularly nanomedicine is experiencing a reproducibility crisis [1]. This crisis has multiples roots\, and can be in part explained by the use of ever more complex experimental protocols and specialized systems [2]\, inaccurate or incomplete description of methods employed and lack of rigor in the design of experimental plan.  However\, another aspect that should not be ignored\, and that possibly contributes to exacerbating this problem is the drift which is currently occurring in the publication practices\, where for some groups\, sharing scientific findings ceases to be the primary reason for publishing their research findings. Using examples taken mainly from the field of drug delivery\, this presentation aims at analyzing the subtle causes that may contribute to the lack of reproducibility of the scientific literature and its impact on the society. It will also provide some possible solutions to disseminate new knowledge in a more reliable fashion. \nReferences: \n[1]. Leroux JC\, Angew. Chem. Int. Ed. 2017\, 56\, 15170-15171. \n[2]. Leroux JC\, J Control. Release 2018\, 278\, 140-141. \n\n\n\n\n\n\n\n\n\n\n\nDr. Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at the ETH Zurich\, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery\, and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS\, EURASC and the CRS\, and the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.
URL:https://scienceinvancouver.com/event/what-has-gone-wrong-with-publication-practices-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220531T090000
DTEND;TZID=America/Vancouver:20220531T103000
DTSTAMP:20220504T165613Z
CREATED:20220504T165613Z
LAST-MODIFIED:20220504T165613Z
UID:28160-1653987600-1653993000@scienceinvancouver.com
SUMMARY:What Has Gone Wrong with Publication Practices?
DESCRIPTION:As in several other scientific disciplines\, pharmaceutical sciences\, and in particularly nanomedicine is experiencing a reproducibility crisis [1]. This crisis has multiples roots\, and can be in part explained by the use of ever more complex experimental protocols and specialized systems [2]\, inaccurate or incomplete description of methods employed and lack of rigor in the design of experimental plan.  However\, another aspect that should not be ignored\, and that possibly contributes to exacerbating this problem is the drift which is currently occurring in the publication practices\, where for some groups\, sharing scientific findings ceases to be the primary reason for publishing their research findings. Using examples taken mainly from the field of drug delivery\, this presentation aims at analyzing the subtle causes that may contribute to the lack of reproducibility of the scientific literature and its impact on the society. It will also provide some possible solutions to disseminate new knowledge in a more reliable fashion. \nReferences: \n[1]. Leroux JC\, Angew. Chem. Int. Ed. 2017\, 56\, 15170-15171. \n[2]. Leroux JC\, J Control. Release 2018\, 278\, 140-141. \n\n\n\n\n\n\n\n\n\n\n\nDr. Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at the ETH Zurich\, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery\, and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS\, EURASC and the CRS\, and the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.
URL:https://scienceinvancouver.com/event/what-has-gone-wrong-with-publication-practices-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220531T090000
DTEND;TZID=America/Vancouver:20220531T103000
DTSTAMP:20220504T165613Z
CREATED:20220504T165613Z
LAST-MODIFIED:20220504T165613Z
UID:31243-1653987600-1653993000@scienceinvancouver.com
SUMMARY:What Has Gone Wrong with Publication Practices?
DESCRIPTION:As in several other scientific disciplines\, pharmaceutical sciences\, and in particularly nanomedicine is experiencing a reproducibility crisis [1]. This crisis has multiples roots\, and can be in part explained by the use of ever more complex experimental protocols and specialized systems [2]\, inaccurate or incomplete description of methods employed and lack of rigor in the design of experimental plan.  However\, another aspect that should not be ignored\, and that possibly contributes to exacerbating this problem is the drift which is currently occurring in the publication practices\, where for some groups\, sharing scientific findings ceases to be the primary reason for publishing their research findings. Using examples taken mainly from the field of drug delivery\, this presentation aims at analyzing the subtle causes that may contribute to the lack of reproducibility of the scientific literature and its impact on the society. It will also provide some possible solutions to disseminate new knowledge in a more reliable fashion. \nReferences: \n[1]. Leroux JC\, Angew. Chem. Int. Ed. 2017\, 56\, 15170-15171. \n[2]. Leroux JC\, J Control. Release 2018\, 278\, 140-141. \n\n\n\n\n\n\n\n\n\n\n\nDr. Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at the ETH Zurich\, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery\, and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS\, EURASC and the CRS\, and the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.
URL:https://scienceinvancouver.com/event/what-has-gone-wrong-with-publication-practices-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20220531T090000
DTEND;TZID=America/Vancouver:20220531T103000
DTSTAMP:20220504T165613Z
CREATED:20220504T165613Z
LAST-MODIFIED:20220504T165613Z
UID:32703-1653987600-1653993000@scienceinvancouver.com
SUMMARY:What Has Gone Wrong with Publication Practices?
DESCRIPTION:As in several other scientific disciplines\, pharmaceutical sciences\, and in particularly nanomedicine is experiencing a reproducibility crisis [1]. This crisis has multiples roots\, and can be in part explained by the use of ever more complex experimental protocols and specialized systems [2]\, inaccurate or incomplete description of methods employed and lack of rigor in the design of experimental plan.  However\, another aspect that should not be ignored\, and that possibly contributes to exacerbating this problem is the drift which is currently occurring in the publication practices\, where for some groups\, sharing scientific findings ceases to be the primary reason for publishing their research findings. Using examples taken mainly from the field of drug delivery\, this presentation aims at analyzing the subtle causes that may contribute to the lack of reproducibility of the scientific literature and its impact on the society. It will also provide some possible solutions to disseminate new knowledge in a more reliable fashion. \nReferences: \n[1]. Leroux JC\, Angew. Chem. Int. Ed. 2017\, 56\, 15170-15171. \n[2]. Leroux JC\, J Control. Release 2018\, 278\, 140-141. \n\n\n\n\n\n\n\n\n\n\n\nDr. Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at the ETH Zurich\, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery\, and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS\, EURASC and the CRS\, and the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.
URL:https://scienceinvancouver.com/event/what-has-gone-wrong-with-publication-practices-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR